Merobat Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Meropenem

Indications/Uses

Pneumonia, nosocomial pneumonia, UTI, intra-abdominal, gynecology (eg, endometritis), skin & skin structure infections; meningitis, septicemia. Empiric treatment in adults w/ suspected febrile neutropenic infections.

Dosage/Direction for Use

Adult Pneumonia, UTI, gynecological infections eg, endometritis, skin & skin structure infections 500 mg IV 8 hrly. Nosocomial pneumonia, peritonitis, suspected febrile neutropenia, septicemia 1 g IV 8 hrly. Meningitis 2 g 8 hrly. Childn 3 mth-12 yr 10-20 mg/kg 8 hrly. Meningitis 40 mg/kg 8 hrly.

Contraindications

Hypersensitivity.

Special Precautions

History of hypersensitivity. Liver disease. History of GI complaint especially colitis. Co-administration w/ other potentially nephrotoxic drugs. Patients w/ CNS disorders or bacterial meningitis &/or impaired kidney functions. Pregnancy & lactation. Infant <3 mth.

Adverse Reactions

Local inj site reactions, systemic allergic reactions, rash, pruritus, urticaria, erythema multiforme, SJS, TEN, abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis, reversible thrombocythemia, eosinophilia, thrombocytopenia, leucopenia, neutropenia, false +ve Coombs' test result; increased serum transaminase, bilirubin, alkaline phosphatase & LDH; headache, paresthesia, convulsion, oral & vag candidiasis.

View ADR Monitoring Form

Drug Interactions

Probenecid, Na valproate.

MIMS Class

Other Beta-Lactams

ATC Classification

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Merobat inj 0.5 g

Packing/Price

1's

Form

Merobat inj 1 g

Packing/Price

1's

Merobat

meropenem

Manufacturer:

Interbat